Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma.
about
Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer.A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer Patients.Therapeutic drug monitoring of targeted anticancer therapy.Continuous low plasma concentrations of everolimus provides equivalent efficacy to oral daily dosing in mouse xenograft models of human cancer.Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer.Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial.Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study proto
P2860
Q37038195-05677B77-1B28-45F5-A7CD-C8DCB6AB6AF2Q37348405-AD73CC52-B816-4253-8C5D-1EDAB61E0D91Q38579278-1C5A9C55-E168-4FD0-9D38-4C066D12D16AQ38695683-554CFE7C-A120-46B2-9898-30F5C911FDCDQ39156308-5A07D2A8-CDDA-4B94-8801-2375731D265CQ39429946-6E5DCBA0-63BF-4A4B-941F-A5B6B4FA928BQ40644710-8DC61541-F537-47C6-8CAE-93E701613E6BQ47339312-8483E3A3-1C63-4EC6-B926-AE6E8A2B6E3CQ48707279-BC14BC4B-A64A-4B9B-819C-1DFF73F1D5B4Q52591387-A7883061-E513-4A98-AB72-1B7388844C29
P2860
Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Impact of everolimus blood con ...... tastatic renal cell carcinoma.
@en
Impact of everolimus blood con ...... tastatic renal cell carcinoma.
@nl
type
label
Impact of everolimus blood con ...... tastatic renal cell carcinoma.
@en
Impact of everolimus blood con ...... tastatic renal cell carcinoma.
@nl
prefLabel
Impact of everolimus blood con ...... tastatic renal cell carcinoma.
@en
Impact of everolimus blood con ...... tastatic renal cell carcinoma.
@nl
P2093
P2860
P1476
Impact of everolimus blood con ...... tastatic renal cell carcinoma.
@en
P2093
A Thiery-Vuillemin
D Montange
G Mouillet
H Almotlak
P Montcuquet
T Nguyen Tan Hon
P2860
P2888
P304
P356
10.1007/S00280-014-2435-7
P577
2014-03-30T00:00:00Z